Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination.
about
Medication and the elderly. Issues of prescription and use.Population pharmacokinetics of nefopam in elderly, with or without renal impairment, and its link to treatment response.Drug prescribing for the elderly.Hepatic drug clearance: the effect of age using indocyanine green as a model compoundA population study of the pharmacokinetics of felodipineThe disposition of antipyrine and its metabolites in young and elderly healthy volunteers.The influence of age, smoking and hyperthyroidism on plasma propranolol steady state concentrationReduced clearance of triazolam in old age: relation to antipyrine oxidizing capacityEffect of inhibitors of prostaglandin synthesis on hepatic drug clearanceThe effects of age and smoking upon antipyrine metabolismFactors affecting the response to inhibition of drug metabolism by cimetidine--dose response and sensitivity of elderly and induced subjects.Pharmacokinetics in the elderly.Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.Drugs and the liver. Part III: Ageing of the liver and the metabolism of drugs.The ability of polycyclic aromatic hydrocarbons to alter physiological factors underlying drug disposition.Aging and determinants of hepatic drug clearance.Drug metabolism in the elderly.Aging, alcohol, and the liver.Multiple-dose pharmacokinetics of concurrent oral ciprofloxacin and rifampin therapy in elderly patients.Pharmacogeriatrics.Drug metabolism in the elderly: confounding of age, smoking, and ethanol effects.Pharmacology and aging.Factors and conditions affecting the glucuronidation of oxazepam.Antipyrine clearance and metabolite formation: the influence of liver volume and smoking.Age-dependent stereoselective increase in the oral clearance of hexobarbitone isomers caused by rifampicin.Lack of effect of ageing on the stereochemical disposition of propranololDrug disposition in patients with HBsAg-positive chronic liver disease.Pharmacokinetics of molsidomine and of its active metabolite, SIN-1 (or linsidomine), in the elderly.Effects of aging on antipyrine clearance: predictive factors of metabolizing capacity.
P2860
Q33630080-831FEEFD-A825-4F89-89BF-A83652673E24Q33887993-A59658EA-FFE9-4683-A9B8-85ABD65DB7D5Q34110511-8F138161-3703-4813-9D5A-0BDF0E4E3346Q34357692-CBE52133-41AF-47EC-8CA0-65ED8AC014DEQ34358245-BA56C3AF-E66E-4DD0-B9C8-81E321825A24Q34416893-0BA3EDF7-95CC-488E-AB9F-A5581EA03217Q34448943-36A16590-67BE-49BD-B4C5-243BF0DCD00CQ34512316-5325F0BE-5764-48B5-B857-9A216E15EC9FQ34512496-FDC51B91-BFEB-4928-A266-A493F028D236Q34518844-ABC2EF35-75BA-4EDE-A3CE-A0F73CEAF35DQ34620821-EDDA95BF-CB06-475E-BC9E-DE3A5A9CF723Q35030828-A18C39C0-0B4A-44DC-A6C8-A67657A273B0Q35608904-67E3E7C0-E62F-47FA-B67A-9A47ACCAA26BQ35674998-444D99C4-6C87-4ADE-826E-7EF5521B0B22Q37913362-694547E0-F717-4D99-9792-DDDB2CDD1851Q38599007-EE0EA563-075B-4483-B313-8C9831A9ECA6Q39522004-AF81EC9E-AF95-46B3-B71C-2B42B14B1213Q39627252-67D79ABE-1837-4B27-A66A-9C805B284FAFQ39815523-926B152F-05F5-44D5-B69A-F9E15FEADA51Q39837842-F8E5237D-9336-41D7-A571-7578ACEA2A3FQ40147811-AE4CCE62-1334-468D-94CF-979D7761BA1AQ40326082-E8C0F27B-D37A-4FDE-91BB-54E5CDF951C3Q40866617-B392A8BD-13B9-416F-9BC0-AA57DBFC755EQ41861668-DD29A75F-8E03-4193-8340-F2DF8132B7E9Q42032895-76B48FA3-93C1-440A-8313-BC91A1EC817FQ42084371-493D2FC6-E044-4556-B21E-69D9D1498D20Q44530397-08966C72-72F5-496B-82C6-58A2911A0833Q44802686-53829B30-A22E-42B6-A7DB-8AEA9550B7B7Q51012501-7BC4754B-E933-4E27-8644-8F92C34E0A3E
P2860
Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination.
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
1979年學術文章
@zh
1979年學術文章
@zh-hant
name
Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination.
@en
type
label
Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination.
@en
prefLabel
Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination.
@en
P2093
P356
P1476
Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination.
@en
P2093
P356
10.1002/CPT197926116
P407
P577
1979-07-01T00:00:00Z